ombitasvir/paritaprevir/ritonavir and dasabuvir

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

AbbVie Corporation

Call for patient/clinician input open:

January 6, 2016

Brand Name:

Holkira Pak

Project Line:

Reimbursement Review

Project Number:

SF0466-000

Call for patient/clinician input closed:

February 25, 2016

NOC Status at Filing:

Post NOC

Submission Type:

Request For Advice

Indications:

Hepatitis C, chronic

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 19, 2016

Last Updated : January 6, 2016